Global law firm Greenberg Traurig, LLP added two attorneys to its Health Care & FDA Practice in Philadelphia: Brad M. Rostolsky joined as a shareholder and Catherine E. David Galea joined as of counsel. Rostolsky comes to Greenberg Traurig after spending the bulk of his career at Reed Smith where Galea worked alongside him.
Combined, these practitioners bring decades of health care regulatory and transactional experience to the firm, part of a larger strategic initiative to strengthen and expand these elements of the practice and its footprint, regionally and nationally.
“Brad brings considerable health care experience and a breadth of cutting-edge insights on developing areas of law, particularly in the areas of data privacy and cybersecurity, that will further enhance this practice and deliver a range of skills and insights for our clients and colleagues,” Health Care & FDA Practice Co-Chairs Tricia A. Asaro and David C. Peck said. “Cate complements and amplifies those offerings. With these additions, we have bolstered not only our tech-focused health legal presence, but also are strengthening our regulatory team, benefitting our clients operating in and around the Mid-Atlantic region and across the country.”
Rostolsky and Galea regularly advise clients – spanning the health care sector spectrum, from hospitals to health plans to electronic health record providers to pharmaceutical and medical device manufacturers- to compliantly engage with the varied requirements the in digital health landscape concerning health information privacy and security compliance under HIPAA and state law. Their experience also includes assisting hospitals with hospital/physician alignment arrangements, such as practice acquisitions, physician recruitment, and counseling on compliance with the Anti-Kickback Statute, the Stark Law, corporate practice of medicine, and Medicare/Medicaid compliance.
“I thought long and hard in choosing to move my practice to Greenberg Traurig. I’ve long been impressed by the entrepreneurial spirit and constant innovative approaches for which Greenberg Traurig is known,” Rostolsky said. “I’ve been particularly impressed by the breadth of experience across so many specific areas. And beyond the stellar capabilities, the firm’s culture, centered on delivering measurable value for clients, was particularly appealing. I look forward to continuing to build out a practice that will best serve the needs of my clients, today and for the future, alongside talented colleagues in Philadelphia and worldwide.”
A graduate of the Thomas R. Kline School of Law of Duquesne University, Rostolsky holds both a bachelor’s and a master’s in public health from Emory University. He is admitted in Pennsylvania and the U.S. District Court for the Eastern District of Pennsylvania.
Galea – formerly Cate David – holds degrees from Dickinson College and Drexel University; at the latter she earned both a J.D. and a master’s in public health. She is barred in Pennsylvania and the District of Columbia.
“These hires were both logical and strategic for Greenberg Traurig and our Philadelphia office, as they help us further align our offerings with our evolving client needs,” said Curtis B. Toll, chair of the Philadelphia office. “Brad’s thought leadership and multidisciplinary practice is tailor-made for our global platform. Cate also shows incredible savvy and promise in this space as a future leader.
“In the past five years, this office has nearly doubled in size, a thoughtful expansion based on laterals of this quality,” Toll added. “It’s a trajectory we hope to continue.”
With Greater Philadelphia ranked among the nation’s Top 10 biotech and life sciences hubs, Rostolsky and Galea’s presence will help the firm better support nascent and established clients in this sector steer through current and emerging legal challenges.
“This team brings an exciting mix of regulatory and transactional strength in the health care and health privacy space that will help this office expand its reach,” said Philadelphia Office Managing Shareholder Alexander L. Scarola. “This is a space we are eager to mine further, given this region’s rooted industries. With these additions, we fully expect to do that, more fully fleshing out the firm’s offerings locally.”
About Greenberg Traurig’s Health Care & FDA Practice: Greenberg Traurig’s multidisciplinary Health Care & FDA Practice provides strategic counsel to a diverse group of companies and other organizations, helping them to respond proactively to the rapidly changing health care marketplace. The group combines dedicated experience in health care regulatory compliance and operational matters with the firm’s capabilities in corporate & securities, finance, tax, antitrust, ERISA, commercial and governmental litigation, restructuring, intellectual property and biotechnology, in order to provide a wide range of legal services.
Source: www.gtlaw.com
